"The next year and a half to two years is going to be very interesting for the entire psychedelic space" as federal regulators consider approval of psychedelics-based treatments, Phillips Lytle's Kyle Mack said.
August 17, 2022 at 06:41 PM
4 minute read
Phillips Lytle on Wednesday joined the growing ranks of firms launching psychedelics practices as researchers study the compounds for possible new treatments for depression, post-traumatic stress disorder and other mental health conditions.
Special counsel Kyle Mack and partner Lisa Smith will lead the regional firm’s psychedelics and mental health therapies practice group. The firm has offices in New York, Chicago, Washington, D.C., and Ontario, Canada.
Presented by BigVoodoo
The New York Law Journal honors attorneys and judges who have made a remarkable difference in the legal profession in New York.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Lower Manhattan firm seeks a premises liability litigator (i.e., depositions, SJ motions, and/or trials) with at least 3-6 years of experien...
Join the Mendocino County District Attorney s Office and work in Mendocino County home to redwoods, vineyards and picturesque coastline. ...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
Phillips Lytle special counsel Kyle Mack, co-leader of the firm’s psychedelics and mental health therapies practice group. Courtesy photo
